Terms: = Bone cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
59 results:
1. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract] [Full Text] [Related]
2. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
[TBL] [Abstract] [Full Text] [Related]
3. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
4. Knocking down sox2 overcomes the resistance of prostate cancer to castration via notch signaling.
Du Z; Chen X; Zhu P; Lv Q; Yong J; Gu J
Mol Biol Rep; 2023 Nov; 50(11):9007-9017. PubMed ID: 37716921
[TBL] [Abstract] [Full Text] [Related]
5. Capsaicin Reduces cancer Stemness and Inhibits Metastasis by Downregulating
Chen ZY; Huang HH; Li QC; Zhan FB; Wang LB; He T; Yang CH; Wang Y; Zhang Y; Quan ZX
Am J Chin Med; 2023; 51(4):1041-1066. PubMed ID: 37120706
[TBL] [Abstract] [Full Text] [Related]
6. Osteogenic and Adipogenic Differentiation Potential of Oral cancer Stem Cells May Offer New treatment Modalities.
Jaksic Karisik M; Lazarevic M; Mitic D; Nikolic N; Milosevic Markovic M; Jelovac D; Milasin J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902135
[TBL] [Abstract] [Full Text] [Related]
7. hPSC-derived sacral neural crest enables rescue in a severe model of Hirschsprung's disease.
Fan Y; Hackland J; Baggiolini A; Hung LY; Zhao H; Zumbo P; Oberst P; Minotti AP; Hergenreder E; Najjar S; Huang Z; Cruz NM; Zhong A; Sidharta M; Zhou T; de Stanchina E; Betel D; White RM; Gershon M; Margolis KG; Studer L
Cell Stem Cell; 2023 Mar; 30(3):264-282.e9. PubMed ID: 36868194
[TBL] [Abstract] [Full Text] [Related]
8. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract] [Full Text] [Related]
9. EID3 Promotes cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway.
Wang Y; Luo S; Wang Y; Yang S; Huang Z; Zhu X; Cai S; Guo Q; Zhong W; Liu S
Oxid Med Cell Longev; 2022; 2022():5941562. PubMed ID: 36071872
[TBL] [Abstract] [Full Text] [Related]
10. ISG15 as a prognostic biomarker in solitary fibrous tumour.
Mondaza-Hernandez JL; Moura DS; Lopez-Alvarez M; Sanchez-Bustos P; Blanco-Alcaina E; Castilla-Ramirez C; Collini P; Merino-Garcia J; Zamora J; Carrillo-Garcia J; Maestro R; Hindi N; Garcia-Foncillas J; Martin-Broto J
Cell Mol Life Sci; 2022 Jul; 79(8):434. PubMed ID: 35864381
[TBL] [Abstract] [Full Text] [Related]
11. cancer Stem Cells and Chemoresistance in Ewing Sarcoma.
Dos Santos RP; Roesler R; Gregianin L; Brunetto AT; da Cunha Jaeger M; Lunardi Brunetto A; de Farias CB
Curr Stem Cell Res Ther; 2023; 18(7):926-936. PubMed ID: 35761483
[TBL] [Abstract] [Full Text] [Related]
12. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
13. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression.
Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
[TBL] [Abstract] [Full Text] [Related]
14. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
Song XJ; Bi MC; Zhu QS; Liu XL
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
[TBL] [Abstract] [Full Text] [Related]
15. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
[TBL] [Abstract] [Full Text] [Related]
16. The sox2 Status of Disseminated Tumor Cells in Breast cancer Patients Treated With Neoadjuvant Chemotherapy.
Krawczyk N; Janowski K; Banys-Paluchowski M; Staebler A; Neubauer H; Meisner C; Hartkopf A; Brucker S; Wallwiener D; Fehm T
Anticancer Res; 2021 Jun; 41(6):2849-2858. PubMed ID: 34083275
[TBL] [Abstract] [Full Text] [Related]
17. Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways.
Han JM; Kim HL; Jung HJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924032
[TBL] [Abstract] [Full Text] [Related]
18. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract] [Full Text] [Related]
19. EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide.
Ciechomska IA; Gielniewski B; Wojtas B; Kaminska B; Mieczkowski J
Exp Mol Med; 2020 Aug; 52(8):1326-1340. PubMed ID: 32788653
[TBL] [Abstract] [Full Text] [Related]
20. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract] [Full Text] [Related]
[Next]
